F R Schneier

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Placebo-controlled trial of moclobemide in social phobia
    F R Schneier
    Department of Therapeutics, New York State Psychiatric Institute, NY 10032, USA
    Br J Psychiatry 172:70-7. 1998
  2. ncbi request reprint Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study
    B A Fallon
    Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York 10032, USA
    Arch Gen Psychiatry 55:918-24. 1998
  3. ncbi request reprint Low dopamine D(2) receptor binding potential in social phobia
    F R Schneier
    Anxiety Disorders Clinic and the Brain Imaging Division, New York State Psychiatric Institute, New York 10032, USA
    Am J Psychiatry 157:457-9. 2000
  4. pmc Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions
    F R Schneier
    New York State Psychiatric Institute, New York, New York, USA
    Psychol Med 40:977-88. 2010

Detail Information

Publications4

  1. ncbi request reprint Placebo-controlled trial of moclobemide in social phobia
    F R Schneier
    Department of Therapeutics, New York State Psychiatric Institute, NY 10032, USA
    Br J Psychiatry 172:70-7. 1998
    ..Moclobemide, a reversible inhibitor of monoamine oxidase A, previously has been reported to have efficacy in the treatment of social phobia...
  2. ncbi request reprint Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study
    B A Fallon
    Department of Psychiatry, Columbia University, New York State Psychiatric Institute, New York 10032, USA
    Arch Gen Psychiatry 55:918-24. 1998
    ..Uncontrolled reports suggest that intravenous clomipramine hydrochloride may be effective for patients with obsessive-compulsive disorder (OCD) who are nonresponsive to oral clomipramine...
  3. ncbi request reprint Low dopamine D(2) receptor binding potential in social phobia
    F R Schneier
    Anxiety Disorders Clinic and the Brain Imaging Division, New York State Psychiatric Institute, New York 10032, USA
    Am J Psychiatry 157:457-9. 2000
    ..This study compared dopamine D(2) receptor binding potential in patients with social phobia and healthy comparison subjects...
  4. pmc Social anxiety disorder and alcohol use disorder co-morbidity in the National Epidemiologic Survey on Alcohol and Related Conditions
    F R Schneier
    New York State Psychiatric Institute, New York, New York, USA
    Psychol Med 40:977-88. 2010
    ..To assess the prevalence and clinical impact of co-morbid social anxiety disorder (SAD) and alcohol use disorders (AUD, i.e. alcohol abuse and alcohol dependence) in a nationally representative sample of adults in the United States...